AMENDED AND RESTATED EMPLOYMENT AGREEMENT Originally Effective March 12, 2003 First Amendment Effective January 1, 2004 Amendment and Restatement Effective May 17, 2006 Second Amendment and Restatement Effective March 1, 2007 Third Amendment and...Employment Agreement • February 25th, 2009 • Gen Probe Inc • Surgical & medical instruments & apparatus • California
THIS EMPLOYMENT AGREEMENT (the “Agreement”) is made by and between Gen-Probe Incorporated, a Delaware corporation with offices at 10210 Genetic Center Drive, San Diego, California 92121 (“Gen-Probe”), and Henry L. Nordhoff (the “Executive”).
SECOND AMENDMENT TO EMPLOYMENT AGREEMENTEmployment Agreement • February 25th, 2009 • Gen Probe Inc • Surgical & medical instruments & apparatus • California
This Second Amendment to Employment Agreement (the “Amendment”) is entered into as of October ___, 2008 (the “Effective Date”), between (the “Executive”) and Gen-Probe Incorporated, a Delaware corporation (“Gen-Probe”).
Gen-Probe Incorporated Second Amendment to Deferred Issuance Restricted Stock Conversion Agreement and Deferred Issuance Restricted Stock Election Agreement (The 2003 Incentive Award Plan)Deferred Issuance Restricted Stock Conversion Agreement and Deferred Issuance Restricted Stock Election Agreement • February 25th, 2009 • Gen Probe Inc • Surgical & medical instruments & apparatus • California
This Second Amendment (the “Amendment”) to the Deferred Issuance Restricted Stock Conversion Agreement (“Conversion Agreement”) and Deferred Issuance Stock Election Agreement (the “Election Agreement”) entered into by and between Gen-Probe Incorporated (the “Company”) and Henry L. Nordhoff (“Employee”) is effective as of October 31, 2008.
FUTURE BLOOD SCREENING ASSAY- ULTRIO 2 ADDENDUM AMENDING AGREEMENT ENTERED INTO AS OF JUNE 11, 1998 BY AND BETWEEN GEN-PROBE INCORPORATED AND NOVARTIS VACCINES & DIAGNOSTICS, INC.Future Blood Screening Assay - Ultrio 2 Addendum • February 25th, 2009 • Gen Probe Inc • Surgical & medical instruments & apparatus
This Future Blood Screening Assay — Ultrio 2 Addendum (the “Ultrio 2 Addendum”) is entered into, effective as of October 1, 2008 (the “Addendum Effective Date”) pursuant to and amending that certain Agreement entered into as of June 11, 1998 (the “Agreement”) by and between Gen-Probe Incorporated, a Delaware corporation (“Gen-Probe”) with a principal place of business at 10210 Genetic Center Drive, San Diego CA 92121, and Novartis Vaccines & Diagnostics, Inc., a Delaware corporation (“Novartis”; and collectively with Gen-Probe, the “parties”) with a place of business at 4560 Horton Street, Emeryville, CA 94608.
AMENDMENT TO EMPLOYMENT AGREEMENTEmployment Agreement • February 25th, 2009 • Gen Probe Inc • Surgical & medical instruments & apparatus • California
This Amendment to Employment Agreement (the “Amendment”) is entered into as of October 31, 2008 (the “Effective Date”), between Carl W. Hull (the “Executive”) and Gen-Probe Incorporated, a Delaware corporation (“Gen-Probe”).
AMENDMENT TO OFFER LETTER AGREEMENTOffer Letter Agreement • February 25th, 2009 • Gen Probe Inc • Surgical & medical instruments & apparatus • California
This Amendment to Offer Letter Agreement (the “Amendment”) is entered into as of October 31, 2008 (the “Effective Date”), between Christina Yang and Gen-Probe Incorporated, a Delaware corporation (“Gen-Probe”).
